Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| TICKER | PRICE | 1D | ▲MKT CAP | P/E | GROSS MARGIN |
|---|---|---|---|---|---|
MRKMerck & Co., Inc. | $148.08 | -0.95% | $365.73B | 41.7x | 0.7% |
LLYEli Lilly & Co. | $1.15K | -1.19% | $1.08T | 40.9x | 0.8% |
JNJJohnson & Johnson | $269.17 | -0.11% | $647.95B | 31.2x | 0.7% |
GILDGilead Sciences, Inc. | $151.37 | +0.54% | $187.94B | 20.6x | 0.8% |
VRTXVertex Pharmaceuticals Incorporated | $516.34 | +1.10% | $131.05B | 30.6x | 0.9% |
BMYBristol-Myers Squibb Co. | $61.15 | -2.35% | $124.87B | 17.1x | 0.7% |
MRNAModerna, Inc. | $182.11 | -0.25% | $72.26B | — | 0.2% |
IDXXIDEXX Laboratories, Inc. | $522.02 | +1.30% | $41.18B | 38.4x | 0.6% |
ALNYAlnylam Pharmaceuticals, Inc. | $246.51 | +0.90% | $32.99B | 60.3x | 0.8% |
ZTSZoetis Inc. | $71.61 | +0.39% | $30.02B | 11.7x | 0.7% |
TECHBio-Techne Corp | $72.52 | +0.07% | $11.35B | 105.1x | 0.6% |